FDA product code DXT: Injector And Syringe, Angiographic

DXT is the FDA product code for injector and syringe, angiographic. It is a Class II device, regulated under 21 CFR 870.1650 and reviewed by the General Hospital panel. FDA has cleared 210 510(k) submissions under DXT, 12 in the last five years, from 88 different applicants. The average 510(k) review took 146 days (median 99); 226 days on average over the last three years. FDA has posted 70 recalls for DXT devices, 21 initiated in the last five years.

Classification

FieldValue
Device nameInjector And Syringe, Angiographic
Device classClass II
Regulation21 CFR 870.1650
Review panelHO — General Hospital
Medical specialtyCardiovascular
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for DXT

YearClearancesAvg. review days
20177156
20189135
20194124
20203183
20211152
20231104
20244192
20251249
20266237

Compare with all 510(k) review times · Search every DXT clearance

Top DXT applicants

ApplicantClearancesLatest
Medrad, Inc.322011-12-15
Osprey Medical, Inc.142019-10-17
Coeur, Inc.102017-08-18
Acist Medical Systems, Inc.82026-05-13
Bayer Medical Care, Inc.72026-02-13

83 more applicants have DXT clearances. See the full list in Caduvo.

Most recent DXT clearances

510(k)ApplicantDeviceDecision dateReview days
K252652Fortis Biosolutions Company LimitedDisposable Syringes with Accessories for Power Injectors (900103T); Disposable Syringes with Accessories for Power Injectors (900103H); Disposable Syringes with Accessories for Power Injectors (801800H); Disposable Syringes with Accessories for Power Injectors (800099T); Disposable Syringes with Accessories for Power Injectors (800099H); Disposable Syringes with Accessories for Power Injectors (800096T); Disposable Syringes with Accessories for Power Injectors (800096H); Disposable Syr2026-05-14265
K252653Acist Medical Systems, Inc.ACIST Pro Diagnostic System (019304); Processing Unit Bed Mount; AngioTouch Module; ACIST Pro Cart; Single Transducer Cable; Triple Transducer Cable2026-05-13264
K252638Acist Medical Systems, Inc.VeraPro S100 Multi-Use Syringe (018808); VeraPro S100 LV1 Low Viscosity Single-Use Syringe (018811); VeraPro AMT Auto-Manifold and Transducer (018814); VeraPro AngioTouch FLX165 Hand Controller Kit (018806); VeraPro AngioTouch HiFi165 Hand Controller Kit (018804)2026-05-13266
K253048Shenzhen Maiwei Biotech Co., Ltd.High Pressure Syringe; Pressure Connecting Tube; Quick fill tube; Spike; Transfer Tube2026-04-16206
K251788Zhuhai DR Medical Instruments Co., Ltd.Extension tube2026-03-05267

Recalls for DXT devices

70 product recalls in 46 recall events; 21 initiated in the last five years and 21 still open. Most recent: 2026-07-31.

YearRecalls
20182
20201
20212
20232
202411
20268

Frequently asked questions

What is FDA product code DXT?

DXT is the FDA product code for injector and syringe, angiographic. It is a Class II device, regulated under 21 CFR 870.1650 and reviewed by the General Hospital panel.

What device class is DXT?

Class II, regulation 21 CFR 870.1650. Typical premarket route: 510(k).

How long does a 510(k) take for product code DXT?

Across 210 cleared submissions the average was 146 days from receipt to decision (median 99).

Which companies have the most DXT clearances?

Medrad, Inc. (32); Osprey Medical, Inc. (14); Coeur, Inc. (10); Acist Medical Systems, Inc. (8); Bayer Medical Care, Inc. (7).

Have DXT devices been recalled?

Yes: 70 product recalls across 46 recall events; the most recent began 2026-07-31.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All General Hospital product codes · FDA product code lookup · 510(k) database search · 510(k) review times